Topics

How HIV/AIDS Activism Led to Broader Patient Activism in Clinical Trials

19:00 EST 13 Feb 2019 | BioSpace

History shows just how slow public health officials, the federal government, regulators and pharmaceutical companies were to respond to the emergence of HIV in the 1980s. The reasons are numerous—it was a puzzling viral disease, it first appeared in what was then a largely stigmatized patient pop...

Original Article: How HIV/AIDS Activism Led to Broader Patient Activism in Clinical Trials

NEXT ARTICLE

More From BioPortfolio on "How HIV/AIDS Activism Led to Broader Patient Activism in Clinical Trials"

Quick Search

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...